Cargando…

Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients

Although the incidence of osteosarcoma (OS) is relatively low compared with other cancer types, the overall survival of metastatic OS was less than 30%. This study aimed to reveal the role of pyroptosis in osteosarcoma and develop a prognostic model related to pyroptosis. Weighted correlation networ...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhe, Jin, Chi, Lu, Xinchang, Zhang, Yan, Zhang, Yi, Wen, Jia, Liu, Yongkui, Liu, Xiaoting, Li, Jiazhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410960/
https://www.ncbi.nlm.nih.gov/pubmed/36035315
http://dx.doi.org/10.1155/2022/1317990
_version_ 1784775213950435328
author Li, Zhe
Jin, Chi
Lu, Xinchang
Zhang, Yan
Zhang, Yi
Wen, Jia
Liu, Yongkui
Liu, Xiaoting
Li, Jiazhen
author_facet Li, Zhe
Jin, Chi
Lu, Xinchang
Zhang, Yan
Zhang, Yi
Wen, Jia
Liu, Yongkui
Liu, Xiaoting
Li, Jiazhen
author_sort Li, Zhe
collection PubMed
description Although the incidence of osteosarcoma (OS) is relatively low compared with other cancer types, the overall survival of metastatic OS was less than 30%. This study aimed to reveal the role of pyroptosis in osteosarcoma and develop a prognostic model related to pyroptosis. Weighted correlation network analysis (WGCNA) was applied to identify key gene modules related to pyroptosis. Univariate Cox regression analysis was used to screen prognostic genes related to pyroptosis. The least absolute shrinkage and selection operator (LASSO) and stepwise Akaike information criterion (stepAIC) were employed to optimize and construct a prognostic model. Five prognostic genes (COL13A1, TNFRSF1A, LILRA6, CTNNBIP1, and CD180) related to pyroptosis were identified. According to the 5-gene signature, OS samples were divided into high- and low-PPRS groups with differential prognosis. Immune-related pathways were more activated in the low-PPRS group. The 5-gene signature was effective and robust to predict OS prognosis. These five prognostic genes were involved in OS development and may serve as new targets for developing therapeutic drugs.
format Online
Article
Text
id pubmed-9410960
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94109602022-08-26 Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients Li, Zhe Jin, Chi Lu, Xinchang Zhang, Yan Zhang, Yi Wen, Jia Liu, Yongkui Liu, Xiaoting Li, Jiazhen J Oncol Research Article Although the incidence of osteosarcoma (OS) is relatively low compared with other cancer types, the overall survival of metastatic OS was less than 30%. This study aimed to reveal the role of pyroptosis in osteosarcoma and develop a prognostic model related to pyroptosis. Weighted correlation network analysis (WGCNA) was applied to identify key gene modules related to pyroptosis. Univariate Cox regression analysis was used to screen prognostic genes related to pyroptosis. The least absolute shrinkage and selection operator (LASSO) and stepwise Akaike information criterion (stepAIC) were employed to optimize and construct a prognostic model. Five prognostic genes (COL13A1, TNFRSF1A, LILRA6, CTNNBIP1, and CD180) related to pyroptosis were identified. According to the 5-gene signature, OS samples were divided into high- and low-PPRS groups with differential prognosis. Immune-related pathways were more activated in the low-PPRS group. The 5-gene signature was effective and robust to predict OS prognosis. These five prognostic genes were involved in OS development and may serve as new targets for developing therapeutic drugs. Hindawi 2022-08-05 /pmc/articles/PMC9410960/ /pubmed/36035315 http://dx.doi.org/10.1155/2022/1317990 Text en Copyright © 2022 Zhe Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Zhe
Jin, Chi
Lu, Xinchang
Zhang, Yan
Zhang, Yi
Wen, Jia
Liu, Yongkui
Liu, Xiaoting
Li, Jiazhen
Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients
title Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients
title_full Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients
title_fullStr Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients
title_full_unstemmed Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients
title_short Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients
title_sort developing a 5-gene signature related to pyroptosis for osteosarcoma patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410960/
https://www.ncbi.nlm.nih.gov/pubmed/36035315
http://dx.doi.org/10.1155/2022/1317990
work_keys_str_mv AT lizhe developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients
AT jinchi developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients
AT luxinchang developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients
AT zhangyan developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients
AT zhangyi developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients
AT wenjia developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients
AT liuyongkui developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients
AT liuxiaoting developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients
AT lijiazhen developinga5genesignaturerelatedtopyroptosisforosteosarcomapatients